dc.contributor.author | Galeano Galeano, Diego Ariel | |
dc.contributor.author | Burgos Edwards, Alberto Javier | |
dc.date.accessioned | 2022-04-06T23:14:53Z | |
dc.date.available | 2022-04-06T23:14:53Z | |
dc.date.issued | 2016 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14066/2841 | |
dc.description.abstract | Abstract—The growing productivity gap between investment in drug research and development (R&D) and the number of new medicines approved by the US Food and Drug Administration (FDA) in the past decade is concerning. This productivity problem raises the need for innovative approaches for drug-target prediction and a deeper understanding of the interplay between drugs and their target proteins. Chemogenomics is the interdisciplinary field which aims to predict gene/protein/ligand relationships. | es |
dc.description.sponsorship | Consejo Nacional de Ciencia y Tecnología | es |
dc.language.iso | eng | es |
dc.subject.classification | 6. Producción y tecnología industrial | es |
dc.subject.other | DRUG | es |
dc.subject.other | PROTEIN-PROTEIN INTERACTION NETWORK | es |
dc.subject.other | GENE/PROTEIN/LIGAND RELATIONSHIPS | es |
dc.subject.other | DRUG TARGETS | es |
dc.subject.other | INDUSTRIA FARMACEUTICA | es |
dc.subject.other | FARMACOLOGIA | es |
dc.title | Drug targets prediction using chemical similarity | es |
dc.type | research article | es |
dc.identifier.doi | 10.1109/CLEI.2016.7833353 | es |
dc.description.fundingtext | PROCIENCIA | es |
dc.relation.projectCONACYT | 14-INV-088 | es |
dc.rights.accessRights | open access | es |
dc.rights.copyright | © 2016 IEEE | es |